DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
Europe - BIT:CPR - NL0015435975 - Common Stock
5.45 EUR
-0.12 (-2.22%)
CPR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 26 industry peers in the Beverages industry. CPR has only an average score on both its financial health and profitability. CPR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CPR was profitable.
In the past year CPR had a positive cash flow from operations.
In the past 5 years CPR has always been profitable.
Each year in the past 5 years CPR had a positive operating cash flow.
1.2 Ratios
CPR has a worse Return On Assets (2.38%) than 65.38% of its industry peers.
CPR's Return On Equity of 5.23% is on the low side compared to the rest of the industry. CPR is outperformed by 73.08% of its industry peers.
With a Return On Invested Capital value of 6.63%, CPR perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 8.66%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROIC | 6.63% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
The Profit Margin of CPR (6.57%) is comparable to the rest of the industry.
CPR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 21.32%, CPR is in line with its industry, outperforming 57.69% of the companies in the same industry.
CPR's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 57.55%, CPR is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CPR has more shares outstanding
CPR has more shares outstanding than it did 5 years ago.
CPR has about the same debt/assets ratio as last year.
2.2 Solvency
CPR has an Altman-Z score of 2.38. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
CPR has a Altman-Z score of 2.38. This is comparable to the rest of the industry: CPR outperforms 57.69% of its industry peers.
CPR has a debt to FCF ratio of 13.61. This is a negative value and a sign of low solvency as CPR would need 13.61 years to pay back of all of its debts.
The Debt to FCF ratio of CPR (13.61) is worse than 65.38% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that CPR is somewhat dependend on debt financing.
CPR's Debt to Equity ratio of 0.66 is fine compared to the rest of the industry. CPR outperforms 65.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Altman-Z | 2.38 |
ROIC/WACC0.99
WACC6.69%
2.3 Liquidity
A Current Ratio of 2.37 indicates that CPR has no problem at all paying its short term obligations.
CPR has a Current ratio of 2.37. This is amongst the best in the industry. CPR outperforms 84.62% of its industry peers.
A Quick Ratio of 0.99 indicates that CPR may have some problems paying its short term obligations.
With an excellent Quick ratio value of 0.99, CPR belongs to the best of the industry, outperforming 88.46% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
CPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.50%.
The Earnings Per Share has been decreasing by -8.12% on average over the past years.
Looking at the last year, CPR shows a small growth in Revenue. The Revenue has grown by 5.18% in the last year.
CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
3.2 Future
The Earnings Per Share is expected to grow by 11.19% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.55% on average over the next years.
EPS Next Y-0.75%
EPS Next 2Y4.05%
EPS Next 3Y6.7%
EPS Next 5Y11.19%
Revenue Next Year2.33%
Revenue Next 2Y2.67%
Revenue Next 3Y3.66%
Revenue Next 5Y4.55%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 32.06, which means the current valuation is very expensive for CPR.
73.08% of the companies in the same industry are cheaper than CPR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.70. CPR is around the same levels.
CPR is valuated correctly with a Price/Forward Earnings ratio of 16.96.
61.54% of the companies in the same industry are cheaper than CPR, based on the Price/Forward Earnings ratio.
CPR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.06 | ||
| Fwd PE | 16.96 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPR is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, CPR is valued a bit more expensive than the industry average as 65.38% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.89 | ||
| EV/EBITDA | 12.39 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.05%
EPS Next 3Y6.7%
5. Dividend
5.1 Amount
CPR has a Yearly Dividend Yield of 1.19%.
Compared to an average industry Dividend Yield of 3.01, CPR's dividend is way lower than its industry peers. On top of this 80.77% of the companies listed in the same industry pay a better dividend than CPR!
Compared to an average S&P500 Dividend Yield of 2.44, CPR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.19% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
38.74% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.74%
EPS Next 2Y4.05%
EPS Next 3Y6.7%
BIT:CPR (10/10/2025, 5:35:15 PM)
5.45
-0.12 (-2.22%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners22.94%
Inst Owner ChangeN/A
Ins Owners51.06%
Ins Owner ChangeN/A
Market Cap6.71B
Analysts70.77
Price Target6.93 (27.16%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.19% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.45%
PT rev (3m)-1.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.16%
EPS NY rev (3m)-2.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.48%
Revenue NY rev (3m)-2.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.06 | ||
| Fwd PE | 16.96 | ||
| P/S | 2.19 | ||
| P/FCF | 31.89 | ||
| P/OCF | 10.01 | ||
| P/B | 1.74 | ||
| P/tB | 147.16 | ||
| EV/EBITDA | 12.39 |
EPS(TTM)0.17
EY3.12%
EPS(NY)0.32
Fwd EY5.9%
FCF(TTM)0.17
FCFY3.14%
OCF(TTM)0.54
OCFY9.99%
SpS2.49
BVpS3.13
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROCE | 9.04% | ||
| ROIC | 6.63% | ||
| ROICexc | 6.65% | ||
| ROICexgc | 14.09% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 6.85% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexcg growth 3Y-20.45%
ROICexcg growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 360.3% | ||
| Cap/Sales | 14.99% | ||
| Interest Coverage | 6.99 | ||
| Cash Conversion | 85.71% | ||
| Profit Quality | 104.37% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 2.38 |
F-Score4
WACC6.69%
ROIC/WACC0.99
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
EPS Next Y-0.75%
EPS Next 2Y4.05%
EPS Next 3Y6.7%
EPS Next 5Y11.19%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
Revenue Next Year2.33%
Revenue Next 2Y2.67%
Revenue Next 3Y3.66%
Revenue Next 5Y4.55%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year24.36%
EBIT Next 3Y12.31%
EBIT Next 5Y10.13%
FCF growth 1Y232.49%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y328.44%
OCF growth 3Y11.5%
OCF growth 5Y13.06%